Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kevin Hrusovsky, Martin Madaus

Premium

Quanterix has named Kevin Hrusovsky executive chairman of its board of directors.

Hrusovsky will replace Martin Madaus, who gave up his chairman seat to be chairman and CEO of Ortho-Clinical Diagnostics but who will remain on the Quanterix board.

Hrusovsky formerly was president of PerkinElmer Life Sciences & Technology. He was CEO of Caliper Life Sciences and joined PerkinElmer after that firm acquired Caliper in 2011 for $600 million. Hrusovsky also previously served as CEO of Zymark, and he was president of FMC Corporation's Pharmaceuticals and International Agricultural Products.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.